mchx-8k_20170504.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 4, 2017

 

 

Marchex, Inc.

(Exact name of Registrant as Specified in its Charter)

 

 

 

Delaware

 

000-50658

 

35-2194038

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

520 Pike Street

Suite 2000

Seattle, Washington 98101

(Address of Principal Executive Offices)

(206) 331-3300

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 

Item 2.02Results of Operations and Financial Condition.

On May 4, 2017, Marchex, Inc. (“Marchex”) is issuing a press release and holding a conference call regarding its financial results for the quarter ended March 31, 2017 (the “Press Release”). The full text of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Marchex is referencing non-GAAP financial information in both the Press Release and on the conference call. A reconciliation of these non-GAAP financial measures to the comparable GAAP financial measures is contained in the attached Press Release. Disclosures regarding definitions of these financial measures used by Marchex and why Marchex’s management believes these financial measures provide useful information to investors is also included in the Press Release. 

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

No.

  

Description

 

 

99.1

  

Press Release of Marchex, dated May 4, 2017.

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Marchex has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 4, 2017

 

MARCHEX, INC.

 

 

 

 

By:

 

/S/    MICHAEL A. ARENDS        

 

 

Name:

 

Michael A. Arends

 

 

Title:

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

mchx-ex991_6.htm

Exhibit 99.1

 

Marchex Announces First Quarter 2017 Results

SEATTLE – May 4, 2017-- Marchex, Inc. (NASDAQ:MCHX), a mobile advertising analytics company, today announced its financial results for the first quarter ended March 31, 2017.

Q1 2017 Financial Highlights

Revenue was $24.4 million for the first quarter of 2017, compared to $36.0 million for the first quarter of 2016.

Net loss was $3.5 million for the first quarter of 2017 or $0.08 per diluted share. For the first quarter of 2016, net loss was $3.7 million or $0.09 per diluted share.

 

 

Q1 2016

 

Q1 2017

Revenue

 

$36.0 million

 

$24.4 million

Non-GAAP Results1:

 

 

 

 

Enterprise Revenue2

 

$27.4 million

 

$19.0 million

Adjusted OIBA3

 

($1.7) million

 

($2.2) million

Adjusted EBITDA3

 

($0.8) million

 

($1.4) million

Cash Balance

 

$107 million

 

$103 million

Adjusted non-GAAP earnings (loss) per share1 was ($0.03) for both the first quarter of 2016 and 2017.

During the first quarter of 2017, YP contributed $5.4 million in revenue, compared to $8.5 million in the first quarter of 2016.

 

1

Reconciliations of non-GAAP measures are included in the financial tables attached to this press release and we encourage investors to examine the reconciling adjustments between the GAAP and non-GAAP measures.

2

Enterprise Revenue represents total revenue less revenue generated from our contracts with YP and other Archeo related transition activities.

3

Includes reorganization costs of approximately $700,000 in Q1 2017.

Strategic Priorities Update

Accelerate Product Innovation.  Marchex Speech Analytics, a new solution launched in April 2017, enables actionable insights for enterprise and mid-sized companies, helping them understand what is happening on inbound phone calls from consumers to their business. Uncovering the intelligence and insights of these consumer calls can empower companies to optimize media spend and sales operations, and enable them to drive more high quality calls to their business and create the opportunity to convert more of those callers into customers.

Marchex Omnichannel Analytics Cloud, launched in February 2017, helps marketers connect customer conversions driven from all paid media channels – including search, display and video, social and sites – to phone calls made to a business. Marketers now have a complete view of which marketing activities are most successful to optimize overall marketing spend and return on investment (ROI) for industries that rely heavily on phone calls.

Expand Strategic Partnerships. Marchex’s February 2017 partnership with Facebook provides marketers a deeper understanding of what happens on a phone call that stems from a Facebook ad. This partnership integrates across Facebook’s social analytics solution into the Marchex Omnichannel Analytics Cloud.

 

 


“Over the last few months, the Office of the CEO has been focused on accelerating Marchex’s product progress and expanding key partnerships to capitalize on the opportunities in our existing business and also open new markets,” said Michael Arends, Chief Financial Officer.  “We are continuing to execute on a series of initiatives to place Marchex back on the path to positive cash generation and to return our company to growth over time.”

Business Outlook

The following forward-looking statements reflect Marchex's expectations as of May 4, 2017.

Financial Guidance for the Second Quarter ending June 30, 2017

 

Revenue

 

$22 million or more

Adjusted OIBA1

 

a loss of $1 million to $2 million

Adjusted EBITDA1

 

breakeven to a loss of $1 million

Conference Call and Webcast Information

Management will hold a conference call, starting at 5:00 p.m. ET on Thursday, May 4, 2017, to discuss its first quarter ended March 31, 2017 financial results and other company updates. Access to the live webcast of the conference call will be available online from the Investors section of Marchex’s website at www.marchex.com.  An archived version of the webcast will also be available at the same location, beginning two hours after completion of the call.

About Marchex

Marchex is a mobile advertising analytics company that connects online behavior to real-world, offline actions.  By linking critical touchpoints in the customer journey, Marchex’s products enable a 360-degree view of marketing effectiveness.  Brands and agencies utilize Marchex’s products to transform business performance. 

Please visit www.marchex.com, www.marchex.com/blog/ or @marchex on Twitter (Twitter.com/Marchex), where Marchex discloses material information from time to time about the Company, its financial information, and its business.

Forward-Looking Statements:

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenues, other financial guidance, acquisitions, dispositions, projected costs, prospects, plans and objectives of management are forward-looking statements. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. There are a number of important factors that could cause Marchex's actual results to differ materially from those indicated by such forward-looking statements which are described in the "Risk Factors" section of our most recent periodic report and registration statement filed with the SEC. All of the information provided in this release is as of May 4, 2017 and Marchex undertakes no duty to update the information provided herein.

Non-GAAP Financial Information:

To supplement Marchex's consolidated financial statements presented in accordance with GAAP and to provide clarity internally and externally, Marchex uses certain non-GAAP measures of financial performance and liquidity, including OIBA, Adjusted OIBA, Adjusted EBITDA, and Adjusted non-GAAP earnings (loss) per share. Marchex also provides Enterprise Revenue, which represents revenue excluding Yellowpages.com LLC (“YP”) revenue generating contracts and other Archeo related transition activities which were insignificant.


OIBA represents income (loss) from operations excluding stock-based compensation expense. This measure, among other things, is one of the primary metrics by which Marchex evaluates the performance of its business. Additionally, Marchex's management uses Adjusted OIBA, which excludes disposition related costs, as this item is not indicative of Marchex’s recurring core operating results. Adjusted OIBA is the basis on which Marchex's internal budgets are based and by which Marchex's management is currently evaluated. Marchex believes these measures are useful to investors because they represent Marchex's consolidated operating results, taking into account depreciation and other intangible amortization, which Marchex believes is an ongoing cost of doing business, but excluding the effects of certain other expenses such as stock-based compensation and disposition related costs. Adjusted EBITDA represents income (loss) before interest, income taxes, depreciation, amortization, stock compensation expense, and disposition related costs. Marchex believes that Adjusted EBITDA is another alternative measure of liquidity to GAAP net cash provided by (used in) operating activities that provides meaningful supplemental information regarding liquidity and is used by Marchex's management to measure its ability to fund operations and its financing obligations.

Financial analysts and investors may use Adjusted OIBA and EBITDA and Enterprise Revenue to help with comparative financial evaluation to make informed investment decisions. Adjusted non-GAAP earnings (loss) per share represents Adjusted non-GAAP net income (loss) applicable to common stockholders divided by GAAP diluted shares outstanding. Adjusted non-GAAP net income (loss) applicable to common stockholders generally captures those items on the statement of operations that have been, or ultimately will be, settled in cash exclusive of certain items that are not indicative of Marchex’s recurring core operating results and represents net income (loss) applicable to common stockholders plus the net of tax effects of: (1) stock-based compensation expense, (2) disposition related costs, and (3) interest and other income (expense). Financial analysts and investors may use Adjusted non-GAAP earnings (loss) per share to analyze Marchex's financial performance since these groups have historically used EPS related measures, along with other measures, to estimate the value of a company, to make informed investment decisions, and to evaluate a company's operating performance compared to that of other companies in its industry.

Marchex's management believes that investors should have access to, and Marchex is obligated to provide, the same set of tools that management uses in analyzing the company's results. These non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, and should not be considered in isolation, as a substitute for, or superior to, GAAP results. Marchex’s non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar titled terms used by other companies, and accordingly, care should be exercised in understanding how Marchex defines its non-GAAP financial measures in this release. Marchex endeavors to compensate for the limitations of the non-GAAP measures presented by providing the comparable GAAP measure with equal or greater prominence, GAAP financial statements, and detailed descriptions of the reconciling items and adjustments, including quantifying such items, to derive the non-GAAP measure.

For further information, contact:

Trevor Caldwell
Marchex Investor Relations

Telephone: 206.331.3600
Email: ir(at)marchex.com

Or

MEDIA INQUIRIES

Marchex Corporate Communications

Telephone: 206.331.3434

Email: pr(at)marchex.com

 


 

MARCHEX, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

 

 

 

Three Months Ended

March 31,

 

 

 

2016

 

 

2017

 

Revenue

 

$

35,985

 

 

$

24,375

 

Expenses:

 

 

 

 

 

 

 

 

Service costs (1)

 

 

21,982

 

 

 

13,598

 

Sales and marketing (1)

 

 

5,522

 

 

 

4,992

 

Product development (1)

 

 

7,472

 

 

 

5,270

 

General and administrative (1)

 

 

4,662

 

 

 

4,030

 

Disposition related costs

 

 

4

 

 

 

 

Total operating expenses

 

 

39,642

 

 

 

27,890

 

Loss from operations

 

 

(3,657

)

 

 

(3,515

)

Interest income (expense) and other, net

 

 

(7

)

 

 

17

 

Loss before provision for income taxes

 

 

(3,664

)

 

 

(3,498

)

Income tax expense

 

 

13

 

 

 

12

 

Net loss applicable to common stockholders

 

$

(3,677

)

 

$

(3,510

)

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per Class A and Class B share applicable to

   common stockholders

 

$

(0.09

)

 

$

(0.08

)

Shares used to calculate basic net loss per share applicable to

   common stockholders:

 

 

 

 

 

 

 

 

Class A

 

 

5,233

 

 

 

5,056

 

Class B

 

 

35,977

 

 

 

37,169

 

Shares used to calculate diluted net loss per share

   applicable to common stockholders:

 

 

 

 

 

 

 

 

Class A

 

 

5,233

 

 

 

5,056

 

Class B

 

 

41,210

 

 

 

42,225

 

 

 

 

 

 

 

 

 

 

(1) Includes stock-based compensation allocated as follows:

 

 

 

 

 

 

 

 

Service costs

 

$

198

 

 

$

125

 

Sales and marketing

 

 

439

 

 

 

406

 

Product development

 

 

532

 

 

 

91

 

General and administrative

 

 

797

 

 

 

735

 

Total

 

$

1,966

 

 

$

1,357

 

 

 


 

MARCHEX, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

 

 

 

December 31,

 

 

March 31,

 

 

 

2016

 

 

2017

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

103,950

 

 

$

103,072

 

Accounts receivable, net

 

 

18,922

 

 

 

16,740

 

Prepaid expenses and other current assets

 

 

1,531

 

 

 

1,853

 

Refundable taxes

 

 

98

 

 

 

87

 

Total current assets

 

 

124,501

 

 

 

121,752

 

Property and equipment, net

 

 

3,557

 

 

 

2,791

 

Other assets, net

 

 

214

 

 

 

213

 

Total assets

 

$

128,272

 

 

$

124,756

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

6,811

 

 

$

5,951

 

Accrued expenses and other current liabilities

 

 

7,707

 

 

 

7,325

 

Deferred revenue

 

 

349

 

 

 

355

 

Total current liabilities

 

 

14,867

 

 

 

13,631

 

Other non-current liabilities

 

 

134

 

 

 

 

Total liabilities

 

 

15,001

 

 

 

13,631

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Class A common stock

 

 

53

 

 

 

53

 

Class B common stock

 

 

380

 

 

 

380

 

Additional paid-in capital

 

 

360,422

 

 

 

361,824

 

Accumulated deficit

 

 

(247,584

)

 

 

(251,132

)

Total stockholders’ equity

 

 

113,271

 

 

 

111,125

 

Total liabilities and stockholders’ equity

 

$

128,272

 

 

$

124,756

 

 

 


 

MARCHEX, INC. AND SUBSIDIARIES

(in thousands)

(unaudited)

 

Reconciliation of GAAP Loss from Operations to Operating Loss Before Amortization (OIBA)

and Adjusted Operating Loss Before Amortization (Adjusted OIBA)

 

 

 

Three Months Ended

March 31,

 

 

 

2016

 

 

2017

 

Loss from operations

 

$

(3,657

)

 

$

(3,515

)

Stock-based compensation

 

 

1,966

 

 

 

1,357

 

Operating loss before amortization (OIBA)

 

 

(1,691

)

 

 

(2,158

)

Disposition related costs

 

 

4

 

 

 

 

Adjusted operating loss before amortization (Adjusted OIBA)1

 

$

(1,687

)

 

$

(2,158

)

 

 

 

Reconciliation from Net Cash used in Operating Activities to Adjusted EBITDA

 

 

 

Three Months Ended

March 31,

 

 

 

2016

 

 

2017

 

Net cash used in operating activities

 

$

(2,267

)

 

$

(878

)

Changes in assets and liabilities

 

 

1,432

 

 

 

(524

)

Income tax expense

 

 

13

 

 

 

12

 

Disposition related costs

 

 

4

 

 

 

 

Interest expense and other, net

 

 

7

 

 

 

(17

)

Adjusted EBITDA1

 

$

(811

)

 

$

(1,407

)

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

$

(475

)

 

$

(6

)

 

 

 

 

 

 

 

 

 

Net cash provided by financing activities

 

$

190

 

 

$

6

 

 

 

1

Includes reorganization costs of approximately $700,000 in Q1 2017.

 

 

 

 

Reconciliation from Revenue to Enterprise Revenue

 

 

 

Three Months Ended

March 31,

 

 

 

2016

 

 

2017

 

Revenue

 

$

35,985

 

 

$

24,375

 

Less: YP Revenue

 

 

8,519

 

 

 

5,402

 

Less: Other

 

 

21

 

 

 

 

Enterprise Revenue2

 

$

27,445

 

 

$

18,973

 

 

 

2

Enterprise Revenue represents total revenue less revenue generated from our contracts with YP and other Archeo related transition activities.

 

 


 

MARCHEX, INC. AND SUBSIDIARIES

 

Reconciliation of GAAP Net Loss per Share to Adjusted Non-GAAP Loss per Share

(in thousands, except per share amounts)

(unaudited)

 

 

 

Three Months Ended

March 31,

 

 

 

2016

 

 

2017

 

Adjusted Non-GAAP loss per share

 

$

(0.03

)

 

$

(0.03

)

 

 

 

 

 

 

 

 

 

Net loss per share applicable to common stockholders - diluted

   (GAAP loss per share)

 

$

(0.09

)

 

$

(0.08

)

Shares used to calculate diluted net loss per share applicable to

   common stockholders

 

 

41,210

 

 

 

42,225

 

 

 

 

 

 

 

 

 

 

Net loss applicable to common stockholders

 

$

(3,677

)

 

$

(3,510

)

Stock-based compensation

 

 

1,966

 

 

 

1,357

 

Disposition related costs

 

 

4

 

 

 

 

Interest (income) expense and other, net

 

 

7

 

 

 

(17

)

Estimated impact of income taxes

 

 

348

 

 

 

714

 

Adjusted Non-GAAP loss

 

$

(1,352

)

 

$

(1,456

)

Adjusted Non-GAAP loss per share

 

$

(0.03

)

 

$

(0.03

)

 

 

 

 

 

 

 

 

 

Shares used to calculate diluted net loss per share applicable to

   common stockholders (GAAP) and Adjusted Non-GAAP loss per share

 

 

41,210

 

 

 

42,225